Product Images Simlandi

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 21 images provide visual information about the product associated with Simlandi NDC 51759-523 by Teva Pharmaceuticals Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Carton1pk - Simlandi carton 1pk 15

Carton1pk - Simlandi carton 1pk 15

This is a medication packaging for Simlandi containing adalimumab-ryvk in the form of an injection. It is a single-dose autoinjector for subcutaneous use. The package includes alcohol prep pads, instructions for use, a medication guide, and prescribing information. The dosage is 40 mg/0.4 mL. The product is labeled for prescription use only.*

Carton2pk - Simlandi carton 2pk 15

Carton2pk - Simlandi carton 2pk 15

This is a description of a medication called Simlandi, containing adalimumab-ryvk in a 40 mg/0.4 mL injection form for subcutaneous use. Each carton contains 2 autoinjectors for single-dose administration along with alcohol preps, instructions for use, medication guide, and prescribing information. It is intended for subcutaneous use only and is available in Braille. The National Drug Code (NDC) for this medication is 51759-402-02.*

1 - simlandi injection bla761299 1

1 - simlandi injection bla761299 1

1 - simlandi injection bla761299 10

1 - simlandi injection bla761299 10

1 - simlandi injection bla761299 11

1 - simlandi injection bla761299 11

1 - simlandi injection bla761299 12

1 - simlandi injection bla761299 12

1 - simlandi injection bla761299 13

1 - simlandi injection bla761299 13

1 - simlandi injection bla761299 14

1 - simlandi injection bla761299 14

1 - simlandi injection bla761299 15

1 - simlandi injection bla761299 15

1 - simlandi injection bla761299 16

1 - simlandi injection bla761299 16

1 - simlandi injection bla761299 17

1 - simlandi injection bla761299 17

1 - simlandi injection bla761299 18

1 - simlandi injection bla761299 18

1 - simlandi injection bla761299 19

1 - simlandi injection bla761299 19

1 - simlandi injection bla761299 2

1 - simlandi injection bla761299 2

This is a comparison of ASAS 20 response between a placebo group with 107 participants and an adalimumab group with 208 participants over a period of 24 weeks. The graph displays the response time in weeks on the x-axis.*

1 - simlandi injection bla761299 3

1 - simlandi injection bla761299 3

1 - simlandi injection bla761299 4

1 - simlandi injection bla761299 4

1 - simlandi injection bla761299 5

1 - simlandi injection bla761299 5

1 - simlandi injection bla761299 6

1 - simlandi injection bla761299 6

1 - simlandi injection bla761299 7

1 - simlandi injection bla761299 7

1 - simlandi injection bla761299 8

1 - simlandi injection bla761299 8

1 - simlandi injection bla761299 9

1 - simlandi injection bla761299 9

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.